Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(S)-2-(Boc-amino)-3-methylbutyric acid, also known as Boc-Vgl-OH, is an important organic intermediate that is widely utilized in the synthesis of various substituted vinylglycine products. It is a white fine crystalline powder, which is a characteristic of N-tert-butoxycarbonyl-L-proline, a related compound. (S)-2-(Boc-amino)-3-methylbutyric acid plays a significant role in the development of pharmaceuticals and other chemical products due to its unique structural properties and reactivity.

13734-41-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 13734-41-3 Structure
  • Basic information

    1. Product Name: (S)-2-(Boc-amino)-3-methylbutyric acid
    2. Synonyms: Bok - L - valine;Boc-Val-OH >=99.0% (T);(2S)-2-(tert-butoxycarbonylamino)-3-methyl-butanoic acid;(2S)-2-[(tert-butoxy-oxomethyl)amino]-3-methylbutanoic acid;(2S)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid;Valine, N-carboxy-, N-tert-butyl ester, L- (8CI);Boc-L-valine≥ 99% (HPLC);N-Boc-L-valine,99%e.e.
    3. CAS NO:13734-41-3
    4. Molecular Formula: C10H19NO4
    5. Molecular Weight: 217.26
    6. EINECS: 237-307-6
    7. Product Categories: Amino Acids;Valine [Val, V];Boc-Amino Acids and Derivative;Amino Acids (N-Protected);Biochemistry;Boc-Amino Acids;Boc-Amino acid series;Pharmaceutical intermediate
    8. Mol File: 13734-41-3.mol
  • Chemical Properties

    1. Melting Point: 77-80 °C(lit.)
    2. Boiling Point: 357.82°C (rough estimate)
    3. Flash Point: 160.5 °C
    4. Appearance: White/Fine Crystalline Powder
    5. Density: 1.1518 (rough estimate)
    6. Vapor Pressure: 1.42E-05mmHg at 25°C
    7. Refractive Index: -6.5 ° (C=1, AcOH)
    8. Storage Temp.: -20°C
    9. Solubility: Chloroform, DMF, DMSO, Methanol
    10. PKA: 4.01±0.10(Predicted)
    11. Water Solubility: insoluble
    12. BRN: 1711290
    13. CAS DataBase Reference: (S)-2-(Boc-amino)-3-methylbutyric acid(CAS DataBase Reference)
    14. NIST Chemistry Reference: (S)-2-(Boc-amino)-3-methylbutyric acid(13734-41-3)
    15. EPA Substance Registry System: (S)-2-(Boc-amino)-3-methylbutyric acid(13734-41-3)
  • Safety Data

    1. Hazard Codes: Xn
    2. Statements: 20/21/22-36/37/38
    3. Safety Statements: 24/25-36-26
    4. WGK Germany: 3
    5. RTECS:
    6. TSCA: Yes
    7. HazardClass: IRRITANT
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 13734-41-3(Hazardous Substances Data)

13734-41-3 Usage

Uses

Used in Pharmaceutical Industry:
(S)-2-(Boc-amino)-3-methylbutyric acid is used as an organic intermediate for the synthesis of substituted vinylglycine products, which are essential in the development of various pharmaceuticals. The versatility of this compound allows it to be a key component in the creation of new drugs and therapeutic agents.
Used in Amino Acid Conjugates:
In the field of proteomics and drug development, (S)-2-(Boc-amino)-3-methylbutyric acid is used in amino acid conjugates as a proteasome inhibitor. Proteasome inhibitors are crucial in the treatment of various diseases, including cancer, by blocking the activity of proteasomes, which are responsible for the degradation of proteins in cells.
Used in Peptide Synthesis:
(S)-2-(Boc-amino)-3-methylbutyric acid is also utilized in multi-peptide synthesis, where it serves as an amino acid protection monomer. This application is vital in the development of peptide-based drugs and therapeutic agents, as it allows for the controlled assembly of peptide chains with specific functionalities and properties.
Used in Chemical Research:
Due to its unique chemical properties and reactivity, (S)-2-(Boc-amino)-3-methylbutyric acid is also used in various chemical research applications. It can be employed as a building block or a starting material for the synthesis of complex organic molecules, contributing to the advancement of chemical science and technology.

Check Digit Verification of cas no

The CAS Registry Mumber 13734-41-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,7,3 and 4 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 13734-41:
(7*1)+(6*3)+(5*7)+(4*3)+(3*4)+(2*4)+(1*1)=93
93 % 10 = 3
So 13734-41-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H19NO4/c1-6(2)7(8(12)13)11-9(14)15-10(3,4)5/h6-7H,1-5H3,(H,11,14)(H,12,13)/p-1/t7-/m0/s1

13734-41-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B1333)  N-(tert-Butoxycarbonyl)-L-valine  >99.0%(T)

  • 13734-41-3

  • 5g

  • 160.00CNY

  • Detail
  • TCI America

  • (B1333)  N-(tert-Butoxycarbonyl)-L-valine  >99.0%(T)

  • 13734-41-3

  • 25g

  • 480.00CNY

  • Detail
  • Alfa Aesar

  • (A16007)  N-Boc-L-valine, 98+%   

  • 13734-41-3

  • 1g

  • 66.0CNY

  • Detail
  • Alfa Aesar

  • (A16007)  N-Boc-L-valine, 98+%   

  • 13734-41-3

  • 5g

  • 293.0CNY

  • Detail
  • Alfa Aesar

  • (A16007)  N-Boc-L-valine, 98+%   

  • 13734-41-3

  • 25g

  • 767.0CNY

  • Detail
  • Aldrich

  • (15528)  Boc-Val-OH  ≥99.0% (T)

  • 13734-41-3

  • 15528-25G

  • 1,278.81CNY

  • Detail
  • Aldrich

  • (15528)  Boc-Val-OH  ≥99.0% (T)

  • 13734-41-3

  • 15528-100G

  • 2,427.75CNY

  • Detail

13734-41-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-2-(Boc-amino)-3-methylbutyric acid

1.2 Other means of identification

Product number -
Other names N-BOC-L-VALINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13734-41-3 SDS

13734-41-3Synthetic route

L-valine
72-18-4

L-valine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane; water100%
With sodium hydroxide In 1,4-dioxane; water at 0℃;100%
With sodium hydroxide In tetrahydrofuran; water at 20℃; for 16h;100%
Boc-Val-NHNHPh
95499-91-5

Boc-Val-NHNHPh

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With oxygen In acetonitrile for 16h; tyrosinase, phosphate buffer pH 7;99%
With phosphate buffer; oxygen; tyrosinase In water; acetonitrile at 20℃; for 16h; pH=7.0;99%
Boc-Val-O-t-Bu
128359-98-8

Boc-Val-O-t-Bu

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With cerium(III) chloride; sodium iodide In acetonitrile for 6h; Heating;99%
With water; iodine In acetonitrile for 5h; Heating;89%
L-valine
72-18-4

L-valine

2-t-butoxycarbonyloxy-3,6-diisopropylpyrazine
104272-92-6

2-t-butoxycarbonyloxy-3,6-diisopropylpyrazine

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine In water; acetonitrile for 24h; Ambient temperature;98%
(S)-(1,1-dioxido-4-oxo-3-phenyl-4H-thiochromen-2-yl)methyl 2-((tert-butoxycarbonyl)amino)-3-methylbutanoate

(S)-(1,1-dioxido-4-oxo-3-phenyl-4H-thiochromen-2-yl)methyl 2-((tert-butoxycarbonyl)amino)-3-methylbutanoate

A

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

B

C16H10O3S
1033736-87-6

C16H10O3S

Conditions
ConditionsYield
In chloroform-d1 for 0.233333h; Photolysis; Inert atmosphere;A 97%
B n/a
L-valine
72-18-4

L-valine

tert-butyl pyridin-2-yl carbonate
89985-91-1

tert-butyl pyridin-2-yl carbonate

A

2-hydroxypyridin
142-08-5

2-hydroxypyridin

B

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine In water; N,N-dimethyl-formamide for 9h; Ambient temperature;A n/a
B 92%
L-valine
72-18-4

L-valine

2,2-dimethylpropanoic anhydride
1538-75-6

2,2-dimethylpropanoic anhydride

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
Stage #1: L-valine With sodium hydroxide In tetrahydrofuran; water at 0 - 20℃;
Stage #2: 2,2-dimethylpropanoic anhydride In tetrahydrofuran; water at 0 - 20℃; for 12h;
90%
((S)-1-benzylcarbamoyl-2-methyl-propyl)-carbamic acid tert-butyl ester
66447-55-0

((S)-1-benzylcarbamoyl-2-methyl-propyl)-carbamic acid tert-butyl ester

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With formic acid; potassium hydroxide In ethanol at 70℃; for 1h;89%
With hydrogen; palladium on activated charcoal
N-tert-butoxycarbonyl-L-valine methyl ester
58561-04-9

N-tert-butoxycarbonyl-L-valine methyl ester

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With lithium hydroxide In methanol for 8h;85%
With water; lithium hydroxide In methanol for 4h;
L-valine
72-18-4

L-valine

tert-butyl 2-oxo-1,3-oxazole-3(2H)-carboxylate
75844-68-7

tert-butyl 2-oxo-1,3-oxazole-3(2H)-carboxylate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With dmap; triethylamine In 1,4-dioxane; water for 15h; Ambient temperature;84%
N-(tert-butoxycarbonyl)valine 1,1-dimethylallyl ester
851714-00-6

N-(tert-butoxycarbonyl)valine 1,1-dimethylallyl ester

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With 4-methyl-morpholine; tetrakis(triphenylphosphine) palladium(0) In tetrahydrofuran at 25℃;84%
L-valine
72-18-4

L-valine

1,2,2,2-Tetrachloroethyl tert-Butyl Carbonate
98015-52-2

1,2,2,2-Tetrachloroethyl tert-Butyl Carbonate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane; water at 20℃; pH=9.2;80%
L-valine
72-18-4

L-valine

O-(tert-butyl) S-(pyridin-2-yl)carbonothioate
105678-24-8

O-(tert-butyl) S-(pyridin-2-yl)carbonothioate

A

2-Mercaptopyridine
2637-34-5

2-Mercaptopyridine

B

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine In water; N,N-dimethyl-formamide for 12h; Ambient temperature;A n/a
B 80%
D-Val-OH
640-68-6

D-Val-OH

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine In water; acetone at 25℃; for 4.5h;70%
L-valine
72-18-4

L-valine

t-butyl S-3,6-diisopropylpyrazin-2-ylthiolcarbonate
104272-95-9

t-butyl S-3,6-diisopropylpyrazin-2-ylthiolcarbonate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With dmap; triethylamine In water; acetonitrile for 24h; Ambient temperature;63%
L-valine
72-18-4

L-valine

tert-Butyl 4-nitrophenyl carbonate
13303-10-1

tert-Butyl 4-nitrophenyl carbonate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With sodium carbonate; tert-butyl alcohol
N-(tert-butyloxycarbonyl) azide
1070-19-5

N-(tert-butyloxycarbonyl) azide

L-valine
72-18-4

L-valine

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane; water
With triethylamine In water; N,N-dimethyl-formamide
tert-butyl (quinolin-8-yl)carbonate
18595-55-6

tert-butyl (quinolin-8-yl)carbonate

L-valine
72-18-4

L-valine

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With sodium hydroxide In N,N-dimethyl-formamide
L-valine
72-18-4

L-valine

tert-butyl fluoroformate
18595-34-1

tert-butyl fluoroformate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With sodium hydroxide In N,N-dimethyl-formamide
L-valine
72-18-4

L-valine

1,1-dimethylethyl 2,4,5-trichlorophenyl carbonate
16965-08-5

1,1-dimethylethyl 2,4,5-trichlorophenyl carbonate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

t-butylpentachlorophenyl carbonate
18942-25-1

t-butylpentachlorophenyl carbonate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine In chloroform; N,N-dimethyl-formamide
L-valine
72-18-4

L-valine

tert-butyl chloroformate
24608-52-4

tert-butyl chloroformate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With sodium hydroxide
With sodium hydroxide In 1,4-dioxane for 16h; Ambient temperature;
With magnesium oxide In diethyl ether; water
phosgene
75-44-5

phosgene

L-valine
72-18-4

L-valine

lithium tert-butoxide
1907-33-1

lithium tert-butoxide

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
Yield given. Multistep reaction;
L-valine
72-18-4

L-valine

2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile
58632-95-4

2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane; water for 4h; Ambient temperature;
L-valine
72-18-4

L-valine

1-(t-butoxycarbonyl)-1,2,4-triazolo<4,3-a>pyridinium-3-olate
50739-44-1

1-(t-butoxycarbonyl)-1,2,4-triazolo<4,3-a>pyridinium-3-olate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With pyridine; sodium hydroxide In acetone for 3h; Ambient temperature;
L-valine
72-18-4

L-valine

tert-butyl α-methoxyvinyl carbonate
81616-10-6

tert-butyl α-methoxyvinyl carbonate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine 1.) dioxane, water, room temp., 30 min, 2.) 20 deg C, 5 h; Yield given. Multistep reaction;
L-valine
72-18-4

L-valine

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

(S)-4-nitrophenyl 2-(tert-butoxycarbonylamino)-3-methylbutanoate
16948-40-6

(S)-4-nitrophenyl 2-(tert-butoxycarbonylamino)-3-methylbutanoate

A

4-nitro-phenol
100-02-7

4-nitro-phenol

B

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With N+C5AlaHis2C16; phosphate buffer pH=7.47; In water at 15 - 40℃; Rate constant; Kinetics; Mechanism; enantioselectivity in ester hydrolysis; other micelle- and vesicle- catalysts; ΔH (excit.); ΔS (excit.); ΔG (excit.);;
dicyclohexylammonium Boc-L-valinate
16944-17-5, 61315-58-0, 102213-00-3

dicyclohexylammonium Boc-L-valinate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With sulfonic acid In ethyl acetate
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

methyl iodide
74-88-4

methyl iodide

Boc-N-Me-Val-OH
45170-31-8

Boc-N-Me-Val-OH

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran at 0 - 23℃; Inert atmosphere;100%
With sodium hydride In tetrahydrofuran at 20℃; for 24h;99%
With sodium hydride In tetrahydrofuran at 0 - 20℃;98%
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Boc-Val-ONSu
3392-12-9

Boc-Val-ONSu

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 72h; Inert atmosphere; Sealed tube;100%
In tetrahydrofuran at 0 - 20℃; for 16h;72%
With dicyclohexyl-carbodiimide In 1,2-dimethoxyethane at 5℃; for 6h;69.5%
chlorosulfuric acid chloromethyl ester
49715-04-0

chlorosulfuric acid chloromethyl ester

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

N-tert-butyloxycarbonyl-L-valine chloromethyl ester
40224-39-3

N-tert-butyloxycarbonyl-L-valine chloromethyl ester

Conditions
ConditionsYield
Stage #1: t-Boc-L-valine With tetra(n-butyl)ammonium hydrogensulfate; sodium hydrogencarbonate In dichloromethane; water at 0℃; for 0.166667h;
Stage #2: chlorosulfuric acid chloromethyl ester In dichloromethane; water at 0 - 20℃; for 19.3333h;
100%
With tetra(n-butyl)ammonium hydrogensulfate; sodium carbonate In dichloromethane; water at 0 - 20℃; for 19.33h;100%
Stage #1: t-Boc-L-valine With tetra(n-butyl)ammonium hydrogensulfate; sodium hydrogencarbonate In dichloromethane; water at 20℃; for 0.0833333h;
Stage #2: chlorosulfuric acid chloromethyl ester In dichloromethane; water at 0 - 20℃; for 2h;
99%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

glycine ethyl ester hydrochloride
5680-79-5

glycine ethyl ester hydrochloride

methyl 2-((2S)-2-((tert-butoxycarbonyl)amino)-3-methylbutanamido)acetate
51803-69-1

methyl 2-((2S)-2-((tert-butoxycarbonyl)amino)-3-methylbutanamido)acetate

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; Inert atmosphere;100%
With cyano-hydroxyimino-acetic acid 2,2-dimethyl-[1,3]dioxolan-4-ylmethyl ester; sodium hydrogencarbonate; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In water at 20℃; for 2h; optical yield given as %de;95%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃; Inert atmosphere;91%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

methyl (2S)-2-amino-3-phenylpropanoate hydrochloride
7524-50-7

methyl (2S)-2-amino-3-phenylpropanoate hydrochloride

N-tert-butoxycarbonyl-L-valyl-L-phenylalanine methyl ester
20902-47-0

N-tert-butoxycarbonyl-L-valyl-L-phenylalanine methyl ester

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 24h;100%
Stage #1: t-Boc-L-valine With 2,6-dimethylpyridine; 6-chloro-3-((dimethylamino)(dimethyliminio)methyl)-1H-benzo[d][1,2,3]triazol-3-ium-1-olatehexafluorophosphate(V); 6-chloro-1-hydroxybenzotriazole In dichloromethane; N,N-dimethyl-formamide at 0℃; for 0.166667h;
Stage #2: methyl (2S)-2-amino-3-phenylpropanoate hydrochloride With 2,6-dimethylpyridine In dichloromethane; N,N-dimethyl-formamide
97%
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In tetrahydrofuran; acetonitrile at 20℃; for 3h;89%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

L-isoleucine benzyl ester tosylate
16652-75-8

L-isoleucine benzyl ester tosylate

(2S,3S)-benzyl-2-{(S)-2-[(tert-butoxycarbonyl)amino]-3-methyl-butanamido}-3-methylpentanoate

(2S,3S)-benzyl-2-{(S)-2-[(tert-butoxycarbonyl)amino]-3-methyl-butanamido}-3-methylpentanoate

Conditions
ConditionsYield
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; triethylamine In water; N,N-dimethyl-formamide for 16h; molar ratio: HOBt:Boc-Val-OH=1:10;100%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In 1,2-dichloro-ethane for 1h; Product distribution; Ambient temperature; other additives, other solvents;82%
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In tetrahydrofuran at 0 - 20℃; for 12h;74%
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃; for 2h;
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

N,O-dimethylhydroxylamine*hydrochloride
6638-79-5

N,O-dimethylhydroxylamine*hydrochloride

tert-butyl (S)-1-(N-methoxy-N-methylcarbamoyl)-2-methylpropylcarbamate
87694-52-8

tert-butyl (S)-1-(N-methoxy-N-methylcarbamoyl)-2-methylpropylcarbamate

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In N,N-dimethyl-formamide at 4℃;100%
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0 - 20℃;100%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;100%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

(S)-4-isopropyloxazolidine-2,5-dione
24601-74-9

(S)-4-isopropyloxazolidine-2,5-dione

Conditions
ConditionsYield
With phosphorus trichloride In dichloromethane at 0℃; for 2h;100%
With bis(trichloromethyl) carbonate; triethylamine In ethyl acetate for 3h; Ambient temperature;75%
Multi-step reaction with 2 steps
1: 50 percent / N-ethyl,N'-(γ-dimethylaminopropyl)-carbodiimide*HCl, triethylamine*HCl / CH2Cl2
2: 90 percent / HCl / CH2Cl2 / 0 °C
View Scheme
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

N-hydroxy-5-norbornene-2,3-dicarboximide
21715-90-2

N-hydroxy-5-norbornene-2,3-dicarboximide

N-(t-butoxycarbonyl)-L-valine N-hydroxy-5-norbornene-2,3-dicarboximide ester
66714-48-5, 68967-04-4

N-(t-butoxycarbonyl)-L-valine N-hydroxy-5-norbornene-2,3-dicarboximide ester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In N,N-dimethyl-formamide; acetonitrile 1.) 0 deg C, 1 h, 2.) RT, 4 h;100%
With WSCD*HCl In N,N-dimethyl-formamide; acetonitrile at 0℃; for 1h;
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

C16H33NO4Si
130529-82-7

C16H33NO4Si

Conditions
ConditionsYield
With triethylamine In ethyl acetate at 0℃; for 0.5h;100%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

methyl 2-amino-3-hydroxypropanoate hydrochloride
5619-04-5

methyl 2-amino-3-hydroxypropanoate hydrochloride

2-((S)-2-tert-Butoxycarbonylamino-3-methyl-butyrylamino)-3-hydroxy-propionic acid methyl ester
793727-88-5

2-((S)-2-tert-Butoxycarbonylamino-3-methyl-butyrylamino)-3-hydroxy-propionic acid methyl ester

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In acetonitrile at 20℃; for 12.0833h;100%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In acetonitrile at 20℃; for 12h;100%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In acetonitrile at 20℃; for 12h;100%
With triethylamine; isobutyl chloroformate 1) THF, -30 deg C, 30 min; 2) THF, -30 deg C --> rt, 6 h, rt, 12 h; Yield given. Multistep reaction;
Stage #1: t-Boc-L-valine With triethylamine; isobutyl chloroformate In tetrahydrofuran at -30℃; for 1h;
Stage #2: methyl 2-amino-3-hydroxypropanoate hydrochloride In tetrahydrofuran at -30 - 20℃; Further stages.;
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

2-tert-butoxycarbonylamino-3-methyl-butyric acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester
345911-01-5

2-tert-butoxycarbonylamino-3-methyl-butyric acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

benzylamine
100-46-9

benzylamine

tert-butyl (S)-1-(benzylamino)-3-methyl-1-oxobutan-2-ylcarbamate
67106-22-3

tert-butyl (S)-1-(benzylamino)-3-methyl-1-oxobutan-2-ylcarbamate

Conditions
ConditionsYield
100%
Stage #1: t-Boc-L-valine With chloroformic acid ethyl ester; triethylamine at 0℃; for 1h; Inert atmosphere;
Stage #2: benzylamine at 0 - 20℃; for 2h; Inert atmosphere;
92%
Stage #1: t-Boc-L-valine With chloroformic acid ethyl ester; triethylamine In dichloromethane at 0℃; for 1h; Inert atmosphere;
Stage #2: benzylamine In dichloromethane at 20℃; for 2h; Inert atmosphere;
90%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

(3aR,6aS)-1-(cyclopropylcarbonyl)-3,3-dimethylhexahydropyrrolo[3,2-b]pyrrol-2(1H)-one hydrochloride

(3aR,6aS)-1-(cyclopropylcarbonyl)-3,3-dimethylhexahydropyrrolo[3,2-b]pyrrol-2(1H)-one hydrochloride

tert-butyl (1S)-{[(3aS,6aR)-4-(cyclopropylcarbonyl)-6,6-dimethyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl}-2-methylpropylcarbamate
488748-91-0

tert-butyl (1S)-{[(3aS,6aR)-4-(cyclopropylcarbonyl)-6,6-dimethyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl}-2-methylpropylcarbamate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In acetonitrile at 20℃;100%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

C13H20N2O2

C13H20N2O2

C23H37N3O5

C23H37N3O5

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In acetonitrile100%
pyrrolidine
123-75-1

pyrrolidine

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

(S)-tert-butyl 3-methyl-1-oxo-1-(pyrrolidin-1-yl)butan-2-ylcarbamate
130013-62-6

(S)-tert-butyl 3-methyl-1-oxo-1-(pyrrolidin-1-yl)butan-2-ylcarbamate

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine In acetonitrile at 20℃;100%
With benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃;82%
With benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; for 24.4167h; Inert atmosphere;82%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Propargylamine
2450-71-7

Propargylamine

(S)-2-methyl-1-(prop-2-ynylcarbamoyl)-propylcarbamic acid t-butyl ester
810671-37-5

(S)-2-methyl-1-(prop-2-ynylcarbamoyl)-propylcarbamic acid t-butyl ester

Conditions
ConditionsYield
With benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane for 2h; Inert atmosphere; Reflux;100%
Stage #1: t-Boc-L-valine With 4-methyl-morpholine; isobutyl chloroformate In dichloromethane at -20℃; for 1h;
Stage #2: Propargylamine In dichloromethane at 20℃; for 16h; Further stages.;
99%
With benzotriazol-1-ol; diisopropyl-carbodiimide In dichloromethane at 0 - 20℃; for 16h; Inert atmosphere;97%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

L-valine benzyl ester p-toluenesulfonate salt
16652-76-9

L-valine benzyl ester p-toluenesulfonate salt

(S)-benzyl 2-((S)-2-((tert-butoxycarbonyl)amino)-3-methylbutanamido)-3-methylbutanoate
77443-49-3

(S)-benzyl 2-((S)-2-((tert-butoxycarbonyl)amino)-3-methylbutanamido)-3-methylbutanoate

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine100%
With benzotriazol-1-ol; dicyclohexyl-carbodiimide In tetrahydrofuran at 20℃;99%
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In tetrahydrofuran at 0 - 20℃; for 12h;87%
With triethylamine; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide at 20℃; for 5h;26%
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In tetrahydrofuran at 0 - 20℃; for 12h; Inert atmosphere;
H-Asp(TMSE)-OBn

H-Asp(TMSE)-OBn

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Boc-Val-Asp(TMSE)-OBn

Boc-Val-Asp(TMSE)-OBn

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 0.75h;100%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 2h;99%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Boc-Val-OBt
68754-63-2

Boc-Val-OBt

Conditions
ConditionsYield
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃;100%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

((S)-1-{(S)-4-benzyl-2-[(R)-(1,2,3,4-tetrahydro-naphthalen-1-yl)carbamoyl]-piperazine-1-carbonyl}-2-methyl-propyl)-carbamic acid tert-butyl ester
913359-77-0

((S)-1-{(S)-4-benzyl-2-[(R)-(1,2,3,4-tetrahydro-naphthalen-1-yl)carbamoyl]-piperazine-1-carbonyl}-2-methyl-propyl)-carbamic acid tert-butyl ester

Conditions
ConditionsYield
Stage #1: (S)-4-benzyl-piperazine-2-carboxylic acid [(1R)-1,2,3,4-tetrahydro-naphthalen-1-yl]-amide With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 1h;
Stage #2: t-Boc-L-valine In N,N-dimethyl-formamide for 1h;
Stage #3: With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate In N,N-dimethyl-formamide at 20℃;
100%
4-N-(tert-butoxycarbonyl)-3'-O-(tert-butyldimethylsilyl)-2'-cyano-2'-deoxy-1-β-D-arabinofuranosylcytosine
903561-50-2

4-N-(tert-butoxycarbonyl)-3'-O-(tert-butyldimethylsilyl)-2'-cyano-2'-deoxy-1-β-D-arabinofuranosylcytosine

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

4-N-(tert-butoxycarbonyl)-5'-O-[N-(tert-butoxycarbonyl)-L-valyl]-3'-O-(tert-butyldimethylsilyl)-2'-cyano-2'-deoxy-1-β-D-arabinofuranosylcytosine
903561-55-7

4-N-(tert-butoxycarbonyl)-5'-O-[N-(tert-butoxycarbonyl)-L-valyl]-3'-O-(tert-butyldimethylsilyl)-2'-cyano-2'-deoxy-1-β-D-arabinofuranosylcytosine

Conditions
ConditionsYield
With dmap; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide In dichloromethane at 0℃; for 3h;100%
4-N-(tert-butoxycarbonyl)-3'-O-(dimethyl-t-hexylsilyl)-2'-cyano-2'-deoxy-1-β-D-arabinofuranosylcytosine
903561-53-5

4-N-(tert-butoxycarbonyl)-3'-O-(dimethyl-t-hexylsilyl)-2'-cyano-2'-deoxy-1-β-D-arabinofuranosylcytosine

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

4-N-(tert-butoxycarbonyl)-3'-O-(dimethyl-t-hexylsilyl)-5'-O-[N-(tert-butoxycarbonyl)-L-valyl]-2'-cyano-2'-deoxy-1-β-D-arabinofuranosylcytosine
903561-54-6

4-N-(tert-butoxycarbonyl)-3'-O-(dimethyl-t-hexylsilyl)-5'-O-[N-(tert-butoxycarbonyl)-L-valyl]-2'-cyano-2'-deoxy-1-β-D-arabinofuranosylcytosine

Conditions
ConditionsYield
With dmap; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide In dichloromethane at 0℃; for 4h;100%
1-(tert-butoxycarbonyl)-L-proline
15761-39-4

1-(tert-butoxycarbonyl)-L-proline

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

N-tert-butoxycarbonyl-L-leucine
13139-15-6

N-tert-butoxycarbonyl-L-leucine

N-tert-butoxycarbonyl-L-phenylalanine
13734-34-4

N-tert-butoxycarbonyl-L-phenylalanine

H-Hphe-Leu-Ile-Ile-Leu-Val-Pro-Pro-Phe-OH
1187223-35-3

H-Hphe-Leu-Ile-Ile-Leu-Val-Pro-Pro-Phe-OH

Conditions
ConditionsYield
Stage #1: Boc-L-homophenylalanine solid phase reaction;
Stage #2: With trifluoroacetic acid In dichloromethane solid phase reaction;
Stage #3: 1-(tert-butoxycarbonyl)-L-proline; t-Boc-L-valine; N-(tert-butyloxycarbonyl)-L-isoleucine; N-tert-butoxycarbonyl-L-leucine; N-tert-butoxycarbonyl-L-phenylalanine Further stages;
100%
1-(tert-butoxycarbonyl)-L-proline
15761-39-4

1-(tert-butoxycarbonyl)-L-proline

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

N-tert-butoxycarbonyl-L-leucine
13139-15-6

N-tert-butoxycarbonyl-L-leucine

N-tert-butoxycarbonyl-L-phenylalanine
13734-34-4

N-tert-butoxycarbonyl-L-phenylalanine

H-Ile-Ile-Leu-Val-Pro-Pro-Hphe-Hphe-Leu-OH
1187223-36-4

H-Ile-Ile-Leu-Val-Pro-Pro-Hphe-Hphe-Leu-OH

Conditions
ConditionsYield
Stage #1: N-tert-butoxycarbonyl-L-leucine solid phase reaction;
Stage #2: With trifluoroacetic acid In dichloromethane solid phase reaction;
Stage #3: 1-(tert-butoxycarbonyl)-L-proline; t-Boc-L-valine; N-(tert-butyloxycarbonyl)-L-isoleucine; N-tert-butoxycarbonyl-L-phenylalanine; Boc-L-homophenylalanine Further stages;
100%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

L-alanine benzyl ester p-toluenesulfonate
42854-62-6

L-alanine benzyl ester p-toluenesulfonate

Boc-Val-Ala-OBzl
77946-33-9

Boc-Val-Ala-OBzl

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine100%
methanol
67-56-1

methanol

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

L-valine methylester hydrochloride
6306-52-1

L-valine methylester hydrochloride

Conditions
ConditionsYield
With thionyl chloride at 0 - 20℃;100%
With thionyl chloride at 20℃; Cooling;
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

4-{5-fluoro-2-[(piperidin-4-yl)oxy]phenyl}morpholine hydrochloride
1189551-08-3

4-{5-fluoro-2-[(piperidin-4-yl)oxy]phenyl}morpholine hydrochloride

t-Butyl [(1S)-1-{[4-(4-fluoro-2-morpholin-4-ylphenoxy)piperidin-1-yl]carbonyl}-2-methylpropyl]carbamate
1189551-09-4

t-Butyl [(1S)-1-{[4-(4-fluoro-2-morpholin-4-ylphenoxy)piperidin-1-yl]carbonyl}-2-methylpropyl]carbamate

Conditions
ConditionsYield
100%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

t-butyl 4-[4-fluoro-2-(methoxycarbonyl)phenoxy]piperidine-1-carboxylate
1189550-98-8

t-butyl 4-[4-fluoro-2-(methoxycarbonyl)phenoxy]piperidine-1-carboxylate

methyl 2-({1-[N-(t-butoxycarbonyl)-L-valyl]piperidin-4-yl}oxy)-5-fluorobenzoate
1189551-00-5

methyl 2-({1-[N-(t-butoxycarbonyl)-L-valyl]piperidin-4-yl}oxy)-5-fluorobenzoate

Conditions
ConditionsYield
Product distribution / selectivity;100%

13734-41-3Relevant articles and documents

The role of the disulfide bond in amyloid-like fibrillogenesis in a model peptide system

Das, Apurba Kumar,Drew, Michael G. B.,Haldar, Debasish,Banerjee, Arindam

, p. 3502 - 3507 (2005)

Three terminally protected short peptides Bis[Boc-D-Leu(1)-Cys(2)-OMe] 1, Bis[Boc-Leu(1)-Cys(2)-OMe] 2 and Bis[Boc-Val(1)-Cys(2)-OMe] 3 exhibit amyloid-like fibrillar morphology. Single crystal X-ray diffraction analysis of peptide 1 clearly demonstrates that it adopts an overall extended backbone molecular conformation that self-assembles to form an intermolecular hydrogen-bonded antiparallel supramolecular β-sheet structure in crystals. Scanning electron microscopic (SEM) images, transmission electron microscopic (TEM) images and Congo red binding studies vividly demonstrate the amyloid-like fibril formation of peptides 1, 2 and 3. However, after reduction of the disulfide bridge of peptides 1, 2 and 3, three newly generated peptides Boc-D-Leu(1)-Cys(2)-OMe 4, Boc-Leu(1)-Cys(2)-OMe 5 and Boc-Val(1)-Cys(2)-OMe 6 are formed and all of them failed to form any kind of fibril under the same conditions, indicating the important role of the disulfide bond in amyloid-like fibrillogenesis in a peptide model system. The Royal Society of Chemistry 2005.

Crystal-to-Crystal Synthesis of Triazole-Linked Pseudo-proteins via Topochemical Azide-Alkyne Cycloaddition Reaction

Krishnan, Baiju P.,Rai, Rishika,Asokan, Aromal,Sureshan, Kana M.

, p. 14824 - 14827 (2016)

Isosteric replacement of amide bond(s) of peptides with surrogate groups is an important strategy for the synthesis of peptidomimetics (pseudo-peptides). Triazole is a well-recognized bio-isostere for peptide bonds, and peptides with one or more triazole units are of great interest for different applications. We have used a catalyst-free and solvent-free method, viz., topochemical azide-alkyne cycloaddition (TAAC) reaction, to synthesize pseudo-proteins with repeating sequences. A designed β-sheet-forming l-Ala-l-Val dipeptide containing azide and alkyne at its termini (N3-Ala-Val-NHCH2C=CH, 1) was synthesized. Single-crystal XRD analysis of the dipeptide 1 showed parallel β-sheet arrangement along the b-direction and head-to-tail arrangement of such β-sheets along the c-direction. This head-to-tail arrangement along the c-direction places the complementary reacting motifs, viz., azide and alkyne, of adjacent molecules in proximity. The crystals of dipeptide 1, upon heating at 85 °C, underwent crystal-to-crystal polymerization, giving 1,4-triazole-linked pseudo-proteins. This TAAC polymerization was investigated by various time-dependent techniques, such as NMR, IR, DSC, and PXRD. The crystal-to-crystal nature of this transformation was revealed from polarizing microscopy and PXRD experiments, and the regiospecificity of triazole formation was evidenced from various NMR techniques. The MALDI-TOF spectrum showed the presence of pseudo-proteins >7 kDa.

Anthracene-labeled pyridinium-based symmetrical chiral chemosensor for enantioselective recognition of l-tartrate

Ghosh, Kumaresh,Sarkar, Tanmay

, p. 1342 - 1346 (2014)

A new anthracene-based chiral chemosensor 1 has been designed and synthesized. l-Valine has been used as the chiral source in the design. The chemosensor 1 has been established as an efficient enantioselective sensor for l-tartrate. While in the presence of l-tartrate the fluorescent sensor 1 in DMSO exhibits considerable increase in emission, the isomeric tartrate brings relatively small change. The enantiomeric fluorescence difference ratio (ef) has been determined to be 29.38.

An improved large scale synthesis of the Schoellkopf chiral auxiliaries: (2R)-and (2S)-2,5-Dihydro-3,6-dimethoxy-2-isopropylpyrazine

Chen, Jianxie,Corbin, Scott P.,Holman, Nicholas J.

, p. 185 - 187 (2005)

Syntheses of the Schoellkopf chiral auxiliaries have been carried out on large scale in high overall yields from D- and L-valine. This method avoids the use of highly toxic phosgene or triphosgene, low-temperature reactions, and unstable intermediates.

A short water-soluble self-assembling peptide forms amyloid-like fibrils

Ray, Sudipta,Das, Apurba K.,Drew, Michael G. B.,Banerjee, Arindam

, p. 4230 - 4232 (2006)

A water-soluble tripeptide Val-Ile-Ala (VIA) 1, bearing sequence identity with the C-terminal portion of the Alzheimer Aβ-peptide (Aβ40-42), self-assembles, in crystalline form, to produce an intermolecularly hydrogen bonded supramolecular β-sheet structure which self-associates to form straight, unbranched nanofibrils exhibiting amyloid-like behavior; in contrast, the synthetic tripeptide Ala-Val-Ile (AVI) 2 self-assembles to produce a β-sheet structure that forms branched nanofibrils which do not show any characteristic features of amyloid-like fibrils. The Royal Society of Chemistry 2006.

An amyloid-like fibril-forming supramolecular cross-β-structure of a model peptide: A crystallographic insight

Maity, Sibaprasad,Kumar, Pankaj,Haldar, Debasish

, p. 3787 - 3791 (2011)

The peptide Boc-Val-Phe-OMe 1 bearing sequence similarity with the central hydrophobic cluster (CHC) of Alzheimer's Aβ18-19 peptide self-assembles to produce amyloid-like straight unbranched fibrils as examined by atomic force microscopy and Congo red assay. Single crystal X-ray diffraction offers the atomic level structure of the supramolecular parallel β-sheet aggregation and antiparallel separation between layers (cross-β-structure).

Enantioselective sensing of lactate by pyridinium-based chiral receptor

Ghosh, Kumaresh,Majumdar, Anupam

, p. 5686 - 5689 (2013)

A simple pyridinium-based chiral receptor 1 containing l-valine as the chiral source has been designed and synthesized. The receptor 1 fluorometrically recognizes d-lactate over l-lactate in CH3CN with an enantiomeric fluorescence ratio (ef) of 5.32.

Short-peptide-based hydrogel: A template for the in situ synthesis of fluorescent silver nanoclusters by using sunlight

Adhikari, Bimalendu,Banerjee, Arindam

, p. 13698 - 13705 (2010)

N-terminally Fmoc-protected dipeptide, Fmoc-Val-Asp-OH, forms a transparent, stable hydrogel with a minimum gelation concentration of 0.2 % w/v. The gelation property of the hydrogel was investigated by using methods such as transmission electron microscopy, field-emission scanning electron microscopy, atomic force microscopy and Fourier transform infrared spectroscopy. The silver-ion-encapsulating hydrogel can efficiently and spontaneously produce fluorescent silver nanoclusters under sunlight at physiological pH (7.46) by using a green chemistry approach. Interestingly, in the absence of any conventional reducing agent but in the presence of sunlight, silver ions were reduced by the carboxylate group of a gelator peptide that contains an aspartic acid residue. These clusters were investigated by using UV/Vis spectroscopy, photoluminescence spectroscopy, high-resolution transmission electron microscopy (HR-TEM), atomic force microscopy (AFM) and X-ray diffraction (XRD) studies. Mass spectrometric analysis shows the presence of a few atoms in nanoclusters containing only Ag2. The reported fluorescent Ag nanoclusters show excellent optical properties, including a very narrow emission profile and large Stokes shift (>100 Nm). The reported fluorescent Ag nanoclusters within hydrogel are very stable even after 6 Months storage in the dark at 4 °C. The as-prepared hydrogel-nanocluster conjugate could have applications in antibacterial preparations, bioimaging and other purposes. Silver nanoparticles: An N-terminally protected dipeptide-based hydrogel has been used to make fluorescent silver nanoclusters in the presence of sunlight at room temperature and at physiological pH by using a green chemistry approach. The fluorescent silver nanoclusters exhibit interesting fluorescence properties with a very narrow emission profile and large Stokes shift that may be useful in future applications. Copyright

Synthesis and biological evaluation of new pleuromutilin derivatives as antibacterial agents

Shang, Ruo-Feng,Wang, Guan-Hua,Xu, Xi-Ming,Liu, Si-Jie,Zhang, Chao,Yi, Yun-Peng,Liang, Jian-Ping,Liu, Yu

, p. 19050 - 19065 (2014)

Several pleuromutilin derivatives possessing thiadiazole moieties were synthesized via acylation reactions under mild conditions. The in vitro antibacterial activities of the derivatives against methicillin-resistant S. aureus, methicillin-resistant S. epidermidis, S. aureus, S. epidermidis, E. coli, and B. cereus were tested by the agar dilution method and Oxford cup assay. All the screened compounds displayed potent activity. Compound 6d was the most active antibacterial agent because of its lowest MIC value and largest inhibition zone. Docking experiments were performed to understand the possible mode of the interactions between the derivatives and 50S ribosomal subunit. Moreover, the absorption, distribution, metabolism, excretion and toxicity properties of the synthesized compounds were analyzed after prediction using the Advanced Chemistry Development/Percepta Platform available online.

Synthesis of Majusculamides A and B

Nakajima, Daisuke,Sueyoshi, Kosuke,Orihara, Kensuke,Teruya, Toshiaki,Yokoshima, Satoshi

, p. 924 - 927 (2019)

The synthesis of two marine lipodipeptides, majusculamides A and B, is described. The key feature of this synthesis is the stereoselective construction of an α-methyl-β-keto-carboxamide moiety.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13734-41-3